Hologic Stock Debt To Equity

HO1 Stock  EUR 68.00  1.00  1.45%   
Hologic fundamentals help investors to digest information that contributes to Hologic's financial success or failures. It also enables traders to predict the movement of Hologic Stock. The fundamental analysis module provides a way to measure Hologic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hologic stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Hologic Company Debt To Equity Analysis

Hologic's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

D/E

 = 

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis

Current Hologic Debt To Equity

    
  134.00 %  
Most of Hologic's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hologic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Competition

According to the company disclosure, Hologic has a Debt To Equity of 134%. This is 150.28% higher than that of the Healthcare sector and 139.97% higher than that of the Medical Instruments & Supplies industry. The debt to equity for all Germany stocks is 175.15% lower than that of the firm.

Hologic Debt To Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hologic's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hologic could also be used in its relative valuation, which is a method of valuing Hologic by comparing valuation metrics of similar companies.
Hologic is currently under evaluation in debt to equity category among its peers.

Hologic Fundamentals

About Hologic Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Hologic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hologic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hologic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Hologic Stock

When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Hologic Stock please use our How to Invest in Hologic guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.